Seikagaku, Discovery Partners International Identify Drug Compound Candidates That Target Sugar Chain Enzymes.Tokyo, Japan, Nov 11, 2005 - (JCNN JCNN Japan Corporate News Network ) - Seikagaku has identified several drug compound candidates that target sugar chain enzymes, in collaboration with its research partner Discovery Partners International (DPI (Dots Per Inch) The measurement of the resolution of display and printing systems. A typical CRT screen provides 96 dpi, which provides 9,216 dots per square inch (96x96). Flat panel displays from 110 to 200 dpi have also been developed. ). By using Seikagaku's proprietary assay method and DPI's exclusive screening system, the two companies have discovered the compound candidates that inhibit inhibit /in·hib·it/ (in-hib´it) to retard, arrest, or restrain. in·hib·it v. 1. To hold back; restrain. 2. the activity of glycosylation enzymes. Seikagaku will proceed with research with a view to developing oral medication using the newly-discovered compounds. Any rights, including patents and development rights, regarding the compounds are vested in Seikagaku. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion